SPIO-enhanced mri findings of well-differentiated hepatocellular carcinomas: correlation with MDCT findings

Korean Journal of Radiology

Volumn 10, Issue 2, 2009, Pages 112-120

  Kim, Seong Hyun ^a   Lee, Won Jae ^a   Lim, Hyo K ^a   Park, Cheol Keun ^a  

^a Sungkyunkwan University School of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

FERUCARBOTRAN; SUPERPARAMAGNETIC IRON OXIDE;

ADULT; AGED; ARTICLE; CONTRAST ENHANCEMENT; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; HUMAN; IMAGE ANALYSIS; LIVER CELL CARCINOMA; MAGNETIC FIELD; MAJOR CLINICAL STUDY; MALE; MULTIDETECTOR COMPUTED TOMOGRAPHY; NUCLEAR MAGNETIC RESONANCE IMAGING; TUMOR VOLUME;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, HEPATOCELLULAR; CONTRAST MEDIA; FEMALE; HUMANS; IMAGE ENHANCEMENT; IMAGE PROCESSING, COMPUTER-ASSISTED; IRON; LIVER NEOPLASMS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; OXIDES; RETROSPECTIVE STUDIES; TOMOGRAPHY, X-RAY COMPUTED;

EID: 66749105346     PISSN: 12296929     EISSN: None     Source Type: Journal    
DOI: 10.3348/kjr.2009.10.2.112     Document Type: Article

References (32)

1. Hussain SM, Zondervan PE, IJzermans JN, Schalm SW, de Man RA, Krestin GP. Benign versus malignant hepatic nodules: MR imaging findings with pathologic correlation. Radiographics 2002;22:1023-1036
2. Lim JH, Kim MJ, Park CK, Kang SS, Lee WJ, Lim HK. Dysplastic nodules in liver cirrhosis: detection with triple phase helical dynamic CT. Br J Radiol 2004;77:911-916
3. Figueras J, Jaurrieta E, Valls C, Ramos E, Serrano T, Rafecas A, et al. Resection or transplantation for hepatocellular carcinoma in cirrhotic patients: outcomes based on indicated treatment strategy. J Am Coll Surg 2000;190:580-587
4. Lim JH, Choi D, Kim SH, Lee SJ, Lee WJ, Lim HK, et al. Detection of hepatocellular carcinoma: value of adding delayed phase imaging to dual-phase helical CT. AJR Am J Roentgenol 2002;179:67-73
5. Iannaccone R, Laghi A, Catalano C, Rossi P, Mangiapane F, Murakami T, et al. Hepatocellular carcinoma: role of unenhanced and delayed phase multi-detector row helical CT in patients with cirrhosis. Radiology 2005;234:460-467
6. Li CS, Chen RC, Tu HY, Shih LS, Zhang TA, Lii JM, et al. Imaging well-differentiated hepatocellular carcinoma with dynamic triple-phase helical computed tomography. Br J Radiol 2006;79:659-665
7. Amano S, Ebara M, Yajima T, Fukuda H, Yoshikawa M, Sugiura N, et al. Assessment of cancer cell differentiation in small hepatocellular carcinoma by computed tomography and magnetic resonance imaging. J Gastroenterol Hepatol 2003;18:273-279
8. Takayasu K, Muramatsu Y, Mizuguchi Y, Moriyama N, Ojima H. Imaging of early hepatocellular carcinoma and adenomatous hyperplasia (dysplastic nodules) with dynamic CT and a combination of CT and angiography: experience with resected liver specimens. Intervirology 2004;47:199-208
9. Murakami T, Hori M, Kim T, Kawata S, Abe H, Nakamura H. Multidetector row CT and MR imaging in diagnosing hepatocel- lular carcinoma. Intervirology 2004;47:209-226
10. Sakabe K, Yamamoto T, Kubo S, Hirohashi K, Hamuro M, Nakamura K, et al. Correlation between dynamic computed tomographic and histopathological findings in the diagnosis of small hepatocellular carcinoma. Dig Surg 2004;21:413-420
11. Tanaka M, Nakashima O, Wada Y, Kage M, Kojiro M. Pathomorphological study of Kupffer cells in hepatocellular carcinoma and hyperplastic nodular lesions in the liver Hepatology 1996;24:807-812
12. Ishida T, Murakami T, Kato N, Takahashi M, Miyazawa T, Tsuda K, et al. Superparamagnetic iron oxide enhanced magnetic resonance imaging of rat liver with hepatocellular carcinoma and benign hyperplastic nodule. Invest Radiol 1997;32:282-287
13. Imai Y, Murakami T, Yoshida S, Nishikawa M, Ohsawa M, Tokunaga K, et al. Superparamagnetic iron oxide-enhanced magnetic resonance images of hepatocellular carcinoma: correlation with histologic grading. Hepatology 2000;32:205-212
14. Kim SH, Choi D, Kim SH, Lim JH, Lee WJ, Kim MJ, et al. Ferucarbotran-enhanced MRI versus triple-phase MDCT for the preoperative detection of hepatocellular carcinoma. AJR Am J Roentgenol 2005;184:1069-1076
15. Kato H, Kanematsu M, Kondo H, Goshima S, Matsuo M, Hoshi H, et al. Ferumoxide-enhanced MR imaging of hepatocellular carcinoma: correlation with histologic tumor grade and tumor vascularity. J Magn Reson Imaging2004;19:76-81
16. Lim JH, Choi D, Cho SK, Kim SH, Lee WJ, Lim HK, et al. Conspicuity of hepatocellular nodular lesions in cirrhotic livers at ferumoxides-enhanced MR imaging: importance of Kupffer cell number. Radiology 2001;220:669-676
17. Pauleit D, Textor J, Bachmann R, Conrad R, Flacke S, Layer G, et al. Hepatocellular carcinoma: detection with gadolinium- and ferumoxides-enhanced MR imaging of the liver. Radiology 2002;222:73-80
18. Tang Y, Yamashita Y, Arakawa A, Namimoto T, Mitsuzaki K, Abe Y, et al. Detection of hepatocellular carcinoma arising in cirrhotic livers: comparison of gadolinium- and ferumoxides- enhanced MR imaging. AJR Am J Roentgenol 1999;172:1547-1554
19. Matsuo M, Kanematsu M, Itoh K, Ito K, Maetani Y, Kondo H, et al. Detection of malignant hepatic tumors: comparison of gadolinium- and ferumoxide-enhanced MR imaging. AJR Am J Roentgenol 2001;177:637-643
20. Nakamura H, Ito N, Kotake F, Mizokami Y, Matsuoka T. umor-detecting capacity and clinical usefulness of SPIO-MRI in patients with hepatocellular carcinoma. J Gastroenterol 000;35:849-855
21. Bartolozzi C, Crocetti L, Lencioni R, Cioni D, Della Pina C, Campani D. Biliary and reticuloendothelial impairment in hepatocarcinogenesis: the diagnostic role of tissue-specific MR contrast media. Eur Radiol 2007;17:2519-2530
22. Takeshita K, Nagashima I, Frui S, Takada K, Yamauchi T, Harasawa A, et al. Effect of superparamagnetic iron oxide- enhanced MRI of the liver with hepatocellular carcinoma and hyperplastic nodule. J Comput Assist Tomogr 2002;26:451-455
23. Kang BK, Lim JH, Kim SH, Choi D, Lim HK, Lee WJ, et al. Preoperative depiction of hepatocellular carcinoma: ferumox- ides-enhanced MR imaging versus triple-phase helical CT. Radiology 2003;226:79-85
24. Edmondson HA, Steiner PE. Primary carcinoma of the liver: a study of 100 cases among 48,900 necropsies. Cancer 1954;7:462-503
25. Kim SH, Lim HK, Choi D, Lee WJ, Kim SH, Kim MJ, et al. Percutaneous radiofrequency ablation of hepatocellular carcinoma: effect of histologic grade on therapeutic results. AJR Am J Roentgenol 2006;186:S327-S333
26. Efremidis SC, Hytiroglou P, Matsui O. Enhancement patterns and signal-intensity characteristics of small hepatocellular carcinoma in cirrhosis: pathologic basis and diagnostic challenges. Eur Radiol 2007;17:2969-2982
27. Hayashi M, Matsui O, Ueda K, Kawamori Y, Kadoya M, Yoshikawa J, et al. Correlation between the blood supply and grade of malignancy of hepatocellular nodules associated with liver cirrhosis: evaluation by CT during intraarterial injection of contrast medium. AJR Am J Roentgenol 1999;172:969-976
28. Sakamoto M, Hirohashi S, Shimosato Y. Early stages of multistep hepatocarcinogenesis: adenomatous hyperplasia and early hepatocellular carcinoma. Hum Pathol 1991;22:172-178
29. International Working Party. Terminology of nodular hepatocel-lular lesions. Hepatology 1995;22:983-993
30. Sugihara S, Nakashima O, Kojiro M, Majima Y, Tanaka M, Tanikawa K. The morphologic transition in hepatocellular carcinoma: a comparison of the individual histologic features disclosed by ultrasound-guided fine-needle biopsy with those of autopsy. Cancer 1992;70:1488-1492
31. Bruix J, Sherman M; Practice Guidelines Committee, American Association for the Study of Liver Diseases. Management of hepatocellular carcinoma. Hepatology 2005;42:1208-1236
32. Chang JM, Lee JM, Lee MW, Choi JY, Kim SH, Lee JY, et al. Superparamagnetic iron oxide-enhanced liver magnetic resonance imaging: comparison of 1.5 T and 3.0 T imaging for detection of focal malignant liver lesions. Invest Radiol 2006;41:168-174